GODAVARIB Godavari Biorefineries Q4 FY25 results (Jan–Mar 2025) and concall
Godavari Biorefineries reported a strong Q4 FY25, with revenue of INR 580 crores and EBITDA of INR 122 crores, driven by debottlenecking in bio-based chemicals and strong ethanol segment performance. FY25 revenue grew 11% to INR 1,870 crores. The company is strategically shifting towards bio-based specialty chemicals and green energy, targeting a 3x increase in EBITDA by FY29, despite ongoing margin pressures in the sugar and ethanol segments.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 321 | 447 | 580 |
| EBITDA | -33 | 36 | 112 |
| Net profit | -75 | 6 | 72 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
